Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
47 Leser
Artikel bewerten:
(0)

Global mHealth App Market Report 2017-2025: Market is Expected to Reach USD 111.8 Bn by 2025, Growing at a CAGR of 44.2%

DUBLIN, October 9, 2017 /PRNewswire/ --

The "mHealth App Market by Type (Fitness, Lifestyle Management, Nutrition & Diet, Women's Health, Healthcare Providers, Disease Management) and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The global mHealth market is expected to reach USD 111.8 billion by 2025, growing at a CAGR of 44.2%

The need to reduce long waiting periods in order to access health care facilities from specialists is the primary driver responsible for the adoption of mHealth.

The availability of applications for consumers are continuing to grow rapidly, especially healthcare apps. These applications assist users in self-management of wellness, disease and chronic abnormalities. This has led to the patient - playing an important and active role in staying informed and updated on their own healthcare decisions, contributing to the rise in adoption of mHealth apps globally.

Healthcare is gradually transitioning towards a precision-based model, better known as a personalized medicine model. mHealth is becoming a widespread trend due to the introduction of technologies such as EMR, remote monitoring, and other communication platforms.

mHealth leverages the 4Ps of healthcare delivery, that is personalized, predictive, participatory, and preventive, to ensure delivery of optimal care to its users. In addition, growing penetration of smartphones, especially in low- & middle-income countries and growing focus on utilizing mobile technology to leverage healthcare delivery and ensure a population health plan is anticipated to benefit the market.

Further key findings from the report suggest:



  • North America accounted for the largest market share owing to its focus toward implementing a successful population health strategy, to reduce healthcare costs
  • Fitness apps account for the largest market share among other mHealth app categories
  • mHealth app vendors are focusing their attention on women's health, diet, and medication reminders. According to Wired, a mobile advertising and analytics platform, women are more inclined toward tracking their health than men
  • Physicians are increasingly recommending usage of mHealth apps to their patients, which is likely to increase the adoption rate of mHealth apps
  • Some of the major market participants in the mHealth apps market are Abbott Laboratories; Johnson & Johnson; AstraZeneca; F. Hoffmann-La Roche AG; Novartis AG; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer; and Sanofi.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 mHealth Apps Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Size and Growth Prospects, 2014 - 2025
3.3 Market Dynamics
3.4 Key Opportunities Prioritized
3.5 Industry Analysis - Porter's
3.6 PESTLE Analysis, 2016
3.7 m-Health apps Competitive Scenario, 2016

Chapter 4 mHealth Apps Market: Type Estimates & Trend Analysis
4.1 m-Health Apps Market: Type Movement Analysis
4.2 Fitness
4.3 Disease Management
4.4 Women's Health
4.5 Lifestyle Management
4.6 Nutrition & Diet
4.7 Healthcare Providers/ Payors
4.8 Medication Adherence
4.9 Others

Chapter 5 mHealth Apps Market: Regional Estimates & Trend Analysis, by Type

Chapter 6 Competitive Landscape

  • Abbott
  • Johnson and Johnson
  • AstraZeneca PLC
  • Roche
  • Novartis
  • Bristol-Myers Squibb
  • GlaxoSmithKline PLC
  • Merck and Co.
  • Pfizer
  • Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/gs7rzf/mhealth_app

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.